These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24682909)

  • 21. The impact of metabolic syndrome on the responsiveness to α1-blocker in men with BPH/LUTS.
    Lee YC; Liu CC; Juan YS; Wu WJ; Li WM; Yeh HC; Wang CJ; Huang CN; Huang CH; Huang SP
    Int J Clin Pract; 2013 Apr; 67(4):356-62. PubMed ID: 23409734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.
    Russo GI; Castelli T; Urzì D; Privitera S; Fragalà E; La Vignera S; Condorelli RA; Calogero AE; Favilla V; Cimino S; Morgia G
    Aging Male; 2015; 18(4):207-16. PubMed ID: 26171768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms.
    Sebastianelli A; Gacci M
    Eur Urol Focus; 2018 Jan; 4(1):25-27. PubMed ID: 29602736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity-initiated metabolic syndrome promotes urinary voiding dysfunction in a mouse model.
    He Q; Babcook MA; Shukla S; Shankar E; Wang Z; Liu G; Erokwu BO; Flask CA; Lu L; Daneshgari F; MacLennan GT; Gupta S
    Prostate; 2016 Aug; 76(11):964-76. PubMed ID: 27040645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of metabolic syndrome and benign prostatic hyperplasia in Chinese patients of different age decades.
    Pan JG; Jiang C; Luo R; Zhou X
    Urol Int; 2014; 93(1):10-6. PubMed ID: 24246728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
    Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
    Russo GI; Cimino S; Fragalà E; Privitera S; La Vignera S; Condorelli R; Calogero AE; Castelli T; Favilla V; Morgia G
    J Sex Med; 2014 Aug; 11(8):2074-82. PubMed ID: 24836928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia.
    Vanella L; Russo GI; Cimino S; Fragalà E; Favilla V; Li Volti G; Barbagallo I; Sorrenti V; Morgia G
    Urology; 2014 Jun; 83(6):1444.e7-13. PubMed ID: 24862399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.
    Russo GI; Vanella L; Castelli T; Cimino S; Reale G; Urzì D; Li Volti G; Gacci M; Carini M; Motta F; Caltabiano R; Puzzo L; Sorrenti V; Morgia G
    World J Urol; 2016 Aug; 34(8):1183-92. PubMed ID: 26621207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cardiovascular risk factors in men with lower urinary tract symptoms.
    Yee CH; Yip JSY; Cheng NMY; Kwan CH; Li KM; Teoh JYC; Chiu PKF; Wong JH; Chan ESY; Chan CK; Hou SSM; Ng CF
    World J Urol; 2019 Apr; 37(4):727-733. PubMed ID: 30083830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes.
    Caretta N; Vigili de Kreutzenberg S; Valente U; Guarneri G; Pizzol D; Ferlin A; Avogaro A; Foresta C
    Andrology; 2015 Nov; 3(6):1062-7. PubMed ID: 26339755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males.
    Chen W; Man S; Wang B; Kadeerhan G; Huang X
    Low Urin Tract Symptoms; 2022 May; 14(3):170-177. PubMed ID: 34882977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The independent association of non-alcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores.
    Eren H; Horsanali MO
    BJU Int; 2019 Aug; 124(2):329-335. PubMed ID: 30900792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
    Park SG; Yeo JK; Cho DY; Park MG
    Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between metabolic syndrome and lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males: evidence based on propensity score matching.
    Xiong Y; Zhang Y; Tan J; Qin F; Yuan J
    Transl Androl Urol; 2021 Jan; 10(1):384-396. PubMed ID: 33532326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.